Product Information
CLINDA-TRETINOIN 1.2%-0.025% is a generic product labeled by Solaris Pharma Corporation, priced at $4.8986 per GM under NDC 73473030630. Its NADAC has been published 211 times since Jun 15, 2022.
Strength
10; .25 mg/g; mg/g
Manufacturer
Solaris Pharma CorporationNDC
73473030630
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
CLINDAMYCIN PHOSPHATE; TRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA212845On Market Since
1/3/2025
Pharmacological Classes
Price Statistics
The NADAC for CLINDA-TRETINOIN 1.2%-0.025% has been published 211 times since Jun 15, 2022, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8986 per GM |
|---|---|
| All-time high | $7.5670 (Oct 11, 2023) |
| All-time low | $4.3997 (Sep 17, 2025) |
| 52-week high | $5.4297 |
| 52-week low | $4.3997 |
| Median price | $5.9181 |
| Average price | $5.7063 |
| Largest weekly change | -31.8% (Dec 20, 2023) |
| Weeks tracked | 211 |
| Tracking since | Jun 15, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLINDA-TRETINOIN 1.2%-0.025%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDA-TRETINOIN 1.2%-0.025%, manufactured by Solaris Pharma Corporation, is $4.8986 per GM (NDC 73473030630), effective Jun 24, 2026.
How has the price of CLINDA-TRETINOIN 1.2%-0.025% changed over time?
Over the history we have for it, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has declined 17.8%. It has been tracked across 211 weekly CMS publications since Jun 15, 2022.
What are the highest and lowest recorded NADAC prices for CLINDA-TRETINOIN 1.2%-0.025%?
Since Jun 15, 2022, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has ranged from a low of $4.3997 (Sep 17, 2025) to a high of $7.5670 (Oct 11, 2023), with a median of $5.9181 per GM.
Are there cheaper alternatives to CLINDA-TRETINOIN 1.2%-0.025%?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CLINDA-TRETINOIN 1.2%-0.025%, is $3.5818 per GM — about 27% below CLINDA-TRETINOIN 1.2%-0.025%.
Who manufactures CLINDA-TRETINOIN 1.2%-0.025%?
CLINDA-TRETINOIN 1.2%-0.025% (NDC 73473030630) is labeled by Solaris Pharma Corporation, and CMS classifies it as a generic product.
Related Drugs
Same classification